Key Record Dates Identifier: NCT03525613
Brief Title: This is a 30-month, Phase III, Multicenter, Randomized, Double-masked, Sham-injection Controlled Study to Assess the Efficacy and Safety of Multiple IVT Injections of APL-2 in Subjects With GA Secondary to AMD

First Submitted : April 20, 2018
First Submitted that Met QC Criteria : May 3, 2018
First Posted : May 15, 2018

Last Update Submitted that Met QC Criteria : September 12, 2019
Last Update Posted : September 13, 2019